Topographic Quantitative EEG Measures of Alpha and Theta Power Changes during Caffeine Withdrawal: Preliminary Findings from Normal Subjects

Gilbert RM . Caffeine consumption. In: Spiller GA (ed). The Methylxanthine Beverages and Foods: Chemistry, Consumption, and Health Effects. New York: Alan R Liss; 1984; 185–213.

Graham DM . Caffeine-its identity, dietary sources, intake, and biological effects. Nutr Rev 1978; 36: 97–102.

Scheiber GB Maffeo CE Robins M . Measurement of coffee and caffeine intake: Implications for epidemiologic research. Prev Med 1988; 17: 280–294.

Hughes JR Oliveto AH Helzer JE . Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10? Am J Psychiatry 1992; 149: 33–40.

Silverman K Evans SM Strain EC Griffiths RR . Withdrawal syndrome after the double-blind cessation of caffeine consumption. New Engl J Med 1992; 327: 1109–1114.

Griffiths RR Evans SM Heighman SJ . Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990; 225: 1123–1132.

Evans SM Griffiths RR . Low dose caffeine physical dependence in normal subjects: dose-related effects. In: Harris L (ed). Problems of Drug Dependence 1990: Proceedings of the 52nd Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph 105. Washington, DC: Government Printing Office; 1991: 446–447.

Greden JF Victor V Fontaine P Lubestsky M . Caffeine-withdrawal headache: a neglected syndrome. In: Scientific Proceedings of the 132nd Annual Meeting, American Psychiatry Association. Chicago: American Psychiatric Association; 1979: 389.

Griffiths RR Woodson PP . Caffeine physical dependence: A review of human and laboratory animal studies. Psychopharmacology (Berl) 1988; 94: 437–451.

Strain EC Munford GK Silverman K Griffiths RR . Caffeine dependence syndrome: Evidence from case histories and experimental evaluations. JAMA 1994; 272: 1043–1048.

Itil TM (ed). Modern Problems of Pharmacopsychiatry, Vol 8, Psychotropic Drugs and the Human EEG. Basel: Karger; 1980.

Fink M . Prediction of clinical activity of psychoactive drugs: Application of cerebral electrometry in phase-1 studies. In: Sudilousky A Gershan S Beer B (eds). Predictability in Psychopharmacology: Preclinical and Clinical Correlations. New York: Raven Press; 1975: 65–87.

Herrmann WM (ed). Electroencephalography in Drug Research. Stuttgart: Fisher; 1982.

Herrmann WM Schaerer E . Pharmaco-EEG: Computer EEG analysis to describe the projection of the drug effects functional cerebral levels in humans. In: Lopes da Silva F Storm van Leeuwen W Rémond A (eds). Handbook of Electroencephalography and Clinical Neurophysiology, Vol 2, Clinical Application of Computer Analysis of EEG and other Neurophysiological Signals. Amsterdam: Elsevier; 1986: 385–445.

Saletu B . EEG imaging of brain activity in clinical psychopharmacology. In: Maurer K (ed). Topographic Brain Mapping of EEG and Evoked Potentials. New York: Springer Verlag; 1989: 482–506.

Goldstein L Murphree HB Pfeiffer CC . Quantitative electroencephalography in man as a measure of CNS stimulation. Ann NY Acad Sci 1963; 107: 1045–1056.

Pritchard WS Robinson JH DeBethizy JD Davis RA Stiles MF . Caffeine and smoking: Subjective, performance and psychophysiological effects. Psychophysiology 1995; 32: 19–27.

Sule J Brozek G Cmiral J . Neurophysiological effects of small doses of caffeine in man. Activitas Nervosa Superior (Praha) 1974; 16: 217–218.

Clubley M Bye CE Henson TA Peck AW Riddington CJ . Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects, and EEG activity. Brit J Pharmacol 1979; 7: 157–163.

Pollock VE Teasdale T Stern J Volavka J . Effects of caffeine on resting EEG and response to sine wave modulated light. Electroencephalogr Clin Neurophysiol 1981; 51: 470–476.